DOD Biotech PCL (BKK:DOD)

Market Cap	283.76M -62.5%
Revenue (ttm)	543.07M -18.0%
Net Income	1.87M -96.1%
EPS	0.00 -96.2%
Shares Out	450.41M
PE Ratio	152.73
Forward PE	n/a
Dividend	0.05 (7.94%)
Ex-Dividend Date	Mar 13, 2026

Volume	322,100
Open	0.6400
Previous Close	0.6200
Day's Range	0.6000 - 0.6400
52-Week Range	0.5600 - 2.0600
Beta	0.80
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 17, 2026

About DOD Biotech PCL

DOD Biotech Public Company Limited, together with its subsidiaries, manufactures and distributes dietary supplements in Thailand. It offers dietary supplements for beauty and health in various forms comprising capsules, gels, jellies, powder, shot drinks, soft gels, tablets, probiotics, gummies, and direct-to-mouth. The company also provides food supplements and health drinks. In addition, it offers advisory, trading, and supplementary services; and research and development, design, FDA and HALAL registration, and consulting services. DOD Biote...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2011
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: DOD

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 9, 2026

Data Sources Report a data error